Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Dec;18(6):677-683.
doi: 10.1007/s11914-020-00627-x. Epub 2020 Oct 8.

The Gut Microbiome and Bone Strength

Macy Castaneda  1 , Jasmin M Strong  1 , Denise A Alabi  1 , Christopher J Hernandez  2
Affiliations
Review

The Gut Microbiome and Bone Strength

Macy Castaneda et al. Curr Osteoporos Rep. 2020 Dec.

Abstract

Purpose of review: Osteoporosis is commonly diagnosed through the clinical assessment of bone quantity using bone mineral density; however, the primary clinical concern is bone fragility. Bone fragility is determined by both bone quantity and bone quality. Over the past decade, the gut microbiome has emerged as a factor that can regulate diseases throughout the body. This review discusses how microbial organisms and their genetic products that inhabit the gastrointestinal tract influence bone quantity, bone quality, and bone strength.

Recent findings: Recent studies have shown that the gut microbiome regulates bone loss during estrogen depletion and glucocorticoid treatment. A series of studies has also shown that the gut microbiome influences whole bone strength by modifying bone tissue quality. The possible links between the gut microbiome and bone tissue quality are discussed focusing on the effects of microbiome-derived vitamin K. We provide a brief introduction to the gut microbiome and how modifications to the gut microbiome may lead to changes in bone. The gut microbiome is a promising target for new therapeutic approaches that address bone quality in ways not possible with current interventions.

Keywords: Bone material properties; Bone quality; Bone quantity; Gut microbiome; Vitamin K.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
A cartoon illustrating links between the gut microbiome and bone in some of the studies discussed in this review [, , ••, ••]. Microbial short chain fatty acids, stimulation of the immune system and microbe-derived vitamin K have been proposed/shown to influence osteoclast and osteoblast activity.
Figure 2.
Figure 2.
The relationship between probability of hip fracture and whole bone strength determined using participant specific finite element models from computed tomography images is shown for women and men [70]. The solid line indicates the age-adjusted logistic regression model expressing fracture probability v. whole bone strength estimated from finite element models assuming normal bone tissue quality (as reported by [56]). Dashed lines indicate the 95% confidence interval of the logistic regression. An impairment of bone tissue quality that reduces whole bone strength by 20% increases the probability of fracture by 100% (red single-headed arrows). The range of whole bone strength corresponding to individuals with osteoporosis and osteopenia as defined by BMD is indicated [56].
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hernandez CJ, van der Meulen MC (2017) Understanding Bone Strength Is Not Enough. J Bone Miner Res 32:1157–1162

      •This review, intended for non-engineers, explains the effects of tissue material properties on whole bone strength

    1. Knight R, Callewaert C, Marotz C, Hyde ER, Debelius JW, McDonald D, Sogin ML (2017) The Microbiome and Human Biology. Annu Rev Genom Hum Genet 18:65–86

      •This review motivates the need for further investigation into the microbiome in human health and disease.

    1. Rajilić-Stojanović M, de Vos WM (2014) The first 1000 cultured species of the human gastrointestinal microbiota. FEMS Microbiol Rev 38:996–1047 - PMC - PubMed
    1. Mimee M, Citorik RJ, Lu TK (2016) Microbiome therapeutics — Advances and challenges. Adv Drug Deliv Rev 105:44–54 - PMC - PubMed
    1. Faith JJ, Guruge JL, Charbonneau M, et al. (2013) The Long-Term Stability of the Human Gut Microbiota. Science 341:1237439. - PMC - PubMed

Publication types